Quick Answer
CorMedix Inc. reported Net Income Loss of $163.06 million for the year ending 2025.
- CorMedix Inc. showed an increase of +1,009.4% in Net Income Loss from 2024 to 2025.
- This data is from CorMedix Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 19 years of available data (2007 to 2025), CorMedix Inc.'s Net Income Loss has grown by 2,352.9%.
- Historical annual values: Fiscal year 2025: $163.06 million | Fiscal year 2024: -$17.93 million | Fiscal year 2023: -$46.34 million | Fiscal year 2022: -$29.70 million | Fiscal year 2021: -$28.21 million | Fiscal year 2020: -$22.03 million | Fiscal year 2019: -$16.43 million | Fiscal year 2018: -$26.83 million | Fiscal year 2017: -$33.01 million | Fiscal year 2016: -$24.64 million | Fiscal year 2015: -$18.19 million | Fiscal year 2014: -$20.45 million | Fiscal year 2013: -$9.13 million | Fiscal year 2012: -$3.38 million | Fiscal year 2011: -$6.71 million | Fiscal year 2010: -$10.91 million | Fiscal year 2009: -$8.12 million | Fiscal year 2008: -$9.00 million | Fiscal year 2007: -$7.24 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: